List of top CEOs of China's Listed Companies in 2018

[industry trends of chinapharma.com] a few days ago, the list of top CEOs of China's Listed Companies in 2018 was released, with a total of 50 people on the list According to relevant statistics, there are nine people in the pharmaceutical industry, accounting for about one fifth of the list I understand that the top three in the pharmaceutical industry are Hao Xiaofeng of Kanghong pharmaceutical, Zhou Yunshu of Hengrui pharmaceutical and Xiang Guangming of xinlitai Kang Hong pharmaceutical Hao Xiaofeng ranking: 14 Kang Hong pharmaceutical President Hao Xiaofeng has been engaged in the pharmaceutical industry for 22 years, Som Yasuhiro Pharmaceutical Biotechnology Department Director, general manager assistant, general manager and vice president of the company Now he is the director and President of the company According to Hao Xiaofeng, Kanghong pharmaceutical devotes 6% of its sales revenue to R & D every year No matter it is Chinese patent medicine, chemical medicine or biological medicine, it has innovation points and constantly meets the clinical needs of the market At present, 12 kinds of drugs have been listed in China Ranking of Hengrui Pharmaceutical Co., Ltd Zhou Yunshu: 16 since December 2003, Zhou Yunshu has been the director and general manager of Jiangsu Hengrui Pharmaceutical Co., Ltd Since 2012, Zhou Yunshu has enjoyed special government allowance from the State Council According to Zhou Yunshu, the future of Hengrui is more important within the company He also believes that in the future, the pharmaceutical enterprises that Hengrui pharmaceutical will have a market value of 100 billion yuan and 200 billion yuan mainly depend on the core of enterprises in medicine, that is, innovation ability plus their own transformation ability Xinlitai project ranking: 24 founded in 1998, xinlitai is a comprehensive pharmaceutical group integrating research and development, production and sales of pharmaceutical products The company has a large number of independent intellectual property products, such as 1.1 innovative blood pressure lowering drug "xinlitan", 3.1 first listed chemical drug "teganine", market anti platelet agglutination drug "TEGA" and other prescription drugs Li Cong, Tonghua Dongbao ranking: since January 2004, Li Cong has been the manager / Marketing Director / general manager assistant of Ganshulin, Tonghua Dongbao sales in East China General manager of Tonghua Dongbao Pharmaceutical Co., Ltd since January 2007 Relevant institutions predict that in the next 3-5 years, Tonghua Dongbao recombinant human insulin series is still expected to achieve a compound growth of 20-25%, which will continue to drive the company's performance growth Ranking of taodesheng of Lizhu group: in 1993, Lizhu was just listed, and the company was in urgent need of promotion Taodesheng transferred from scientific research to market promotion, made advertising planning, and then began to make brand and CI After Lizhu acquired Limin, Tao Desheng returned to Limin again During this period, he put forward the concept of "digital Chinese medicine" in the industry and practiced the theory of "digital Chinese medicine" with Shenqi Fuzheng injection as the carrier It was not until 2005 that Tao Desheng returned to Zhuhai to serve as vice president of Lizhu group, and since 2014, President of Lizhu group has been working Cao Longxiang ranking of Jichuan pharmaceutical: 39 facing the new opportunities and challenges brought by the great development and reform of the pharmaceutical industry, Cao Longxiang, who is good at overall operation, innovative thinking and strategic design, is leading Jichuan pharmaceutical to buy a brand development strategy At present, Jichuan pharmaceutical is based on the big health industry, expanding the industrial chain, expanding the product group, vigorously promoting the construction of Health Industrial Park in the transformation and upgrading, and constantly promoting enterprises to scale, capitalization and internationalization Lin Gang ranking of kangzhe pharmaceutical: 41 in 1995, Lin Gang purchased Shenzhen kangzhe Pharmaceutical Co., Ltd (now a wholly-owned subsidiary of kangzhe pharmaceutical Holding Co., Ltd.) through his company, so that it established its business from a small company engaged in the sale of drugs and developed into a pharmaceutical service company providing marketing, promotion and sales services Lin Gang has clinical experience and rich experience in marketing, promotion and sales of Chinese pharmaceutical products and other value-added services Cai Dongchen ranking of Shiyao group: in 1984, Cai Dongchen served as the director of Hebei Pharmaceutical Factory, chairman and President of Hebei Pharmaceutical Group Co., Ltd in 1994, and chairman of Shiyao Group Co., Ltd since 1997 Cai Dongchen has set up a three-level scientific and Technological Development System in the group, subsidiary and workshop of Shiyao group, each of which has its own emphasis and complements each other, thus bringing the enterprise's technological innovation and new product development to a new level As an entrepreneur, Cai Dongchen, while promoting the development of enterprises, has a high sense of social responsibility, enthusiastically supports social public welfare undertakings, and adheres to both economic and social benefits Liu Jianshun ranking: 48 Liu Jianshun, chairman of the board of directors of the pharmaceutical industry, has successively served as the organization section chief, deputy section chief of the party and masses section, cadre of the Organization Department, organization member at the level of the municipal Party committee, chief of the dry audit section of the organization Department, and deputy director of the Beijing Office of the Zhangzhou municipal government Liu Jianshun once said: "if we want to" go out ", we must set up the signboards of" national culture "and" traditional Chinese medicine culture ", and promote brand communication with traditional Chinese medicine culture communication, so that enterprises can go faster, better and further."